• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

Hepatitis Tags: Hepatitis B

SAMHSA chief urges grantees and partners to address infectious diseases as integral part of the response to the substance use disorders epidemic.
Hepatitis B
USPSTF reaffirms recommendation on screening for hepatitis B infection in pregnant women at their first prenatal visit to prevent infection in newborns.
Tagged: Hepatitis B
New Funding Opportunity Announcement from NIH’s NIAID will support research on a hepatitis B cure for HIV/HBV coinfection and HBV monoinfection.
Posted in: Research
Tagged: Hepatitis B
In The News
New CDC viral hepatitis chief comes from state health department leadership and brings experience in research, outbreak response, and strategic partnerships.
U.S. Preventive Services Task Force logo
USPSTF invites public comment on its draft research plan for screening for hepatitis B virus infection in nonpregnant adolescents and adults.
Tagged: Hepatitis B
Help shape the objectives for Healthy People 2030. Submit your comments today!
The U.S. Department of Health and Human Services (HHS) is soliciting written comments on the proposed objectives for Healthy People 2030 through January 17, 2019. This public comment period will allow comments on the proposed HP2030 objectives and members of the public can also propose their own objectives.
Posted in: Global Health
NRV and NHAS callouts
ADM Brett Giroir, MD, Assistant Secretary for Health at HHS, initiated the process to develop the next editions of NVHAP and NHAS, both of which expire in 2020.
Hepatitis B
This blog showcases the work of several community partners in addressing the stigma and discrimination that can be associated with viral hepatitis
Tagged: Hepatitis B
CDC logo
The 7 indicators in CDC’s 2018 National Viral Hepatitis Progress Report provide a way to assess progress toward achieving key viral hepatitis goals.
Hepatitis B
The Food and Drug Administration (FDA) is an important federal partner in implementing the National Viral Hepatitis Action Plan and has just invited comment on important new guidance for industry in developing new drugs for hepatitis B virus (HBV) treatment. Please share this notice with colleagues in the field and consider submitting comments as we work toward developing improved treatments for HBV.
Tagged: Hepatitis B


  • of 10
  • >